Clinical Trial Update: Safety and Tolerability Study of INCB057643 in Participants With Myelofibrosis and Other Advanced Myeloid Neoplasms [Phase 1]

View source ↗

Summary

An update on a Phase 1 safety and tolerability study of INCB057643 in myelofibrosis and other advanced myeloid neoplasms, with the trial currently active but no…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Thrombocythemia
• Myelodysplastic Myeloproliferative Neoplasm Overlap Syndrome
• Myelodysplastic Syndrome
• Myelofibrosis
• Myeloproliferative Neoplasms
• Or Refractory Primary Myelofibrosis
• Post-essential Thrombocythemia Myelofibrosis
• Post-polycythemia Vera Myelofibrosis

Drugs mentioned

• INCB057643

Snippet

Sponsor: Incyte Corporation | Conditions: Myelofibrosis, Myelodysplastic Syndrome | Phase 1 | Status: ACTIVE_NOT_RECRUITING